IL81020A - History of FSC-MG protein A method for making and using such proteins - Google Patents

History of FSC-MG protein A method for making and using such proteins

Info

Publication number
IL81020A
IL81020A IL8102086A IL8102086A IL81020A IL 81020 A IL81020 A IL 81020A IL 8102086 A IL8102086 A IL 8102086A IL 8102086 A IL8102086 A IL 8102086A IL 81020 A IL81020 A IL 81020A
Authority
IL
Israel
Prior art keywords
csf
plasmid
sequence
fragment
fusion protein
Prior art date
Application number
IL8102086A
Other languages
English (en)
Hebrew (he)
Other versions
IL81020A0 (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL81020A0 publication Critical patent/IL81020A0/xx
Publication of IL81020A publication Critical patent/IL81020A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL8102086A 1985-12-21 1986-12-18 History of FSC-MG protein A method for making and using such proteins IL81020A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853545568 DE3545568A1 (de) 1985-12-21 1985-12-21 Gm-csf-protein, seine derivate, herstellung solcher proteine und ihre verwendung

Publications (2)

Publication Number Publication Date
IL81020A0 IL81020A0 (en) 1987-03-31
IL81020A true IL81020A (en) 1995-11-27

Family

ID=6289242

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8102086A IL81020A (en) 1985-12-21 1986-12-18 History of FSC-MG protein A method for making and using such proteins

Country Status (17)

Country Link
EP (1) EP0228018B1 (fr)
JP (1) JP2575367B2 (fr)
KR (1) KR940005585B1 (fr)
AT (1) ATE71144T1 (fr)
AU (2) AU601959B2 (fr)
CA (1) CA1341197C (fr)
DE (2) DE3545568A1 (fr)
DK (1) DK170346B1 (fr)
ES (1) ES2055686T3 (fr)
FI (1) FI91168C (fr)
GR (1) GR3003999T3 (fr)
HU (1) HU202584B (fr)
IE (1) IE59779B1 (fr)
IL (1) IL81020A (fr)
NO (1) NO177270C (fr)
PT (1) PT83972B (fr)
ZA (1) ZA869557B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5078996A (en) * 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
WO1987002060A1 (fr) * 1985-10-03 1987-04-09 Biogen N.V. Polypeptides semblables aux facteurs de stimulation de colonies de granulocytes-macrophages (gm-csf) et leurs procedes de production en quantites importantes dans des cellules microbiennes
DE3712985A1 (de) * 1987-04-16 1988-11-03 Hoechst Ag Bifunktionelle proteine
US5359035A (en) * 1985-12-21 1994-10-25 Hoechst Aktiengesellschaft Bifunctional proteins including interleukin-2 (IL-2) and granuloctyte macrophage colony stimulating factor (GM-CSF)
JP2583770B2 (ja) * 1986-09-17 1997-02-19 大塚製薬株式会社 遺伝子
JPS6420097A (en) * 1987-03-02 1989-01-24 Sumitomo Chemical Co Human granulocyte-macrophage colony stimulating factor
AU609128B2 (en) * 1987-04-02 1991-04-26 Amrad Operations Pty. Limited Leukaemia-inhibitory factor
PT87133B (pt) * 1987-04-02 1992-07-31 Amrad Corp Ltd Metodo de purificacao do factor inibidor da leucemia (lif) e de composicoes farmaceuticas contendo polipeptidos com actividade do lif
WO1988010310A1 (fr) * 1987-06-25 1988-12-29 Immunex Corporation Facteur de stimulation de colonies de granulocytes-macrophages bovins
EP0386109A1 (fr) * 1987-11-12 1990-09-12 Schering Corporation Acceleration de formation osseuse a l'aide de gm-csf
GB2212159B (en) * 1987-11-13 1992-01-22 British Bio Technology Synthetic gene for human granulocyte/macrophage colony stimulating factor.
EP0413721A4 (en) * 1988-04-21 1991-11-13 Medvet Science Pty. Ltd. Human gm-csf variants
WO1990012877A1 (fr) * 1989-04-19 1990-11-01 Cetus Corporation Proteines m-csf multifonctionnelles et codage de genes pour celles-ci
WO1991002754A1 (fr) * 1989-08-22 1991-03-07 Immunex Corporation Proteines de fusion comprenant gm-csf et il-3
NZ236819A (en) * 1990-02-03 1993-07-27 Max Planck Gesellschaft Enzymatic cleavage of fusion proteins; fusion proteins; recombinant dna and pharmaceutical compositions
US5270181A (en) * 1991-02-06 1993-12-14 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
US6060258A (en) * 1995-09-28 2000-05-09 Otsuka Pharmaceutical Co., Ltd. Neutrophil chemotactic lymphokine, and method for the diagnosis of drug hypersensitive granulocytopenia using the same
KR100448021B1 (ko) * 2001-12-28 2004-09-08 크레아젠 주식회사 마우스 과립구 대식세포 콜로니 촉진인자 발현벡터 ｐＧＭ-ＣＳＦ로 형질전환된 대장균 및 상기 마우스 과립구 대식세포 콜로니 촉진인자의 대량생산방법
WO2011079070A1 (fr) 2009-12-23 2011-06-30 Gradalis, Inc. Arn bifonctionnel désactivant la furine
SG10201606680QA (en) 2009-12-23 2016-10-28 Gradalis Inc Furin-knockdown and gm-csf-augmented (fang) cancer vaccine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438032A (en) * 1981-01-30 1984-03-20 The Regents Of The University Of California Unique T-lymphocyte line and products derived therefrom
SE8300693L (sv) * 1983-02-09 1984-08-10 Sven Lofdahl Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
AU594014B2 (en) * 1984-03-21 1990-03-01 Research Corporation Technologies, Inc. Recombinant DNA molecules
EP0188479B1 (fr) * 1984-07-06 1991-09-11 Sandoz Ag Production et purification de lymphokine
ZA856108B (en) * 1984-10-29 1986-10-29 Immunex Corp Cloning of human granulocyte-macrophage colony simulating factor gene
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
KR920003822B1 (ko) * 1984-11-20 1992-05-15 쉐링 바이오텍 코포레이션 인체 과립구 대식 세포 및 호산성 세포 성장 인자 활성을 나타내는 폴리펩티드
WO1987002060A1 (fr) * 1985-10-03 1987-04-09 Biogen N.V. Polypeptides semblables aux facteurs de stimulation de colonies de granulocytes-macrophages (gm-csf) et leurs procedes de production en quantites importantes dans des cellules microbiennes
DE3541856A1 (de) * 1985-11-27 1987-06-04 Hoechst Ag Eukaryotische fusionsproteine, ihre herstellung und verwendung sowie mittel zur durchfuehrung des verfahrens
DE3636903A1 (de) * 1985-12-21 1987-07-02 Hoechst Ag Fusionsproteine mit eukaryotischem ballastanteil

Also Published As

Publication number Publication date
AU6675686A (en) 1987-06-25
NO865191D0 (no) 1986-12-19
IE59779B1 (en) 1994-04-06
ES2055686T3 (es) 1994-09-01
IL81020A0 (en) 1987-03-31
HU202584B (en) 1991-03-28
DE3545568A1 (de) 1987-07-16
CA1341197C (fr) 2001-03-06
EP0228018B1 (fr) 1992-01-02
FI91168B (fi) 1994-02-15
NO177270B (no) 1995-05-08
DK619086D0 (da) 1986-12-19
AU637139B2 (en) 1993-05-20
NO177270C (no) 1995-08-16
KR870006188A (ko) 1987-07-09
DE3683267D1 (de) 1992-02-13
ZA869557B (en) 1987-10-28
FI865186A0 (fi) 1986-12-18
PT83972A (de) 1987-01-01
PT83972B (pt) 1989-07-31
AU6268390A (en) 1990-12-13
JPS62164695A (ja) 1987-07-21
DK619086A (da) 1987-06-22
AU601959B2 (en) 1990-09-27
IE863335L (en) 1987-06-21
NO865191L (no) 1987-06-22
DK170346B1 (da) 1995-08-07
GR3003999T3 (fr) 1993-03-16
KR940005585B1 (ko) 1994-06-21
EP0228018A2 (fr) 1987-07-08
JP2575367B2 (ja) 1997-01-22
HUT44615A (en) 1988-03-28
FI865186A (fi) 1987-06-22
EP0228018A3 (en) 1987-12-02
FI91168C (fi) 1994-05-25
ATE71144T1 (de) 1992-01-15

Similar Documents

Publication Publication Date Title
IL81020A (en) History of FSC-MG protein A method for making and using such proteins
CA1341203C (fr) Proteines de fusion eucaryotiques contenant des sequences d'interleukin-2
US5359035A (en) Bifunctional proteins including interleukin-2 (IL-2) and granuloctyte macrophage colony stimulating factor (GM-CSF)
US5017692A (en) Truncated human interleukin-a alpha
DE3750056T2 (de) Polypeptid-Mutanten des menschlichen TNF und für diese Mutanten codierende DNS.
JP2541761B2 (ja) ミュレル管抑制物質様ポリペプチドおよびその製造方法
KR970000187B1 (ko) 이작용성 단백질, 이의 제조방법 및 이를 포함하는 약제
CA1339892C (fr) Preparation de polypeptides ayant l'activite du gamme-interferon humain
HU221416B1 (en) Hil-4mutant proteins used as antagonists or partial agonists of human interleukin 4
AU617999B2 (en) A genetic engineering process for the preparation of angiogenins
HU196846B (en) Process for producing biologically active derivatives of human gamma-interferon and pharmaceutical compositions comprising the same
US5298603A (en) GM-CSF protein, its derivatives, the preparation of proteins of this type, and their use
DE3751081T2 (de) [Leu 13] Motilin, dessen kodierende DNS-Moleküle und Verfahren zu dessen Herstellung.
HU197939B (en) Process for producing deoxyribonucleic acid, or its precursor, determining human growth hormone releasing factor
US5545564A (en) Vector for expression and secretion of polypeptide microorganism transformed by the vector and production of polypeptide with the same microorganism
DE69630630T2 (de) Staphylococcus aureus V8 Protease Mutanten
HU215947B (hu) Eljárás alfa-hélix 1, vagy alfa-hélix 1 és alfa-hélix 3 régiójukban módosított szomatotropinok előállítására
HUT62659A (en) Process for the increased expression of recombinant polypeptides of small molecular weight
JP2568383B2 (ja) ポリペプチドをコード化するｄｎａ配列
KR100197110B1 (ko) 활성 사람 호중구 화학주성 인자 폴리펩티드의 제조방법
HU200939B (en) Process for stabilizing htnf obtained by recombinant dna technique
JPH06503553A (ja) 改良されたドメイン間幾何を有するキメラ毒素類
GB2210618A (en) Synthetic gene
JPH069692A (ja) 新規ペプチド、該ペプチドをコードする組換えｄｎａおよび該組換えｄｎａにより形質転換された微生物

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed